The US government has awarded Novavax Inc $1.6 billion to cover testing, commercialisation and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021, Reuters reported.

The award is the biggest yet from “Operation Warp Speed”, the White House programme aimed at accelerating access to vaccines and treatments to fight the coronavirus.

Read full story here.